Concepedia

Mark E.T. Penfold

ME

Statistics

Publications

29

Citations

5K

H-Index

24

Active since

1994

Affiliations

ChemoCentryx (United States)(Current)

Stanford University

Westmead Hospital

Tokyo Medical and Dental University

The University of Sydney

Mark E.T. Penfold is an author at ChemoCentryx (United States) specializing in life sciences, cell signaling, and immunology.

Publications per year

1994–2014

29

Publications

29

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

Jennifer M. Burns, Bretton C. Summers, Yu Wang et al. · The Journal of Experimental Medicine · 2006 · 1.3K citations · Full text

, , +17

Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis

Bi‐Sen Ding, Zhongwei Cao, Raphaël Lis et al. · Nature · 2013 · 620 citations · Full text

, , +14

C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN

Hong Xiao, Daniel J. Dairaghi, Jay P. Powers et al. · Journal of the American Society of Nephrology · 2013 · 356 citations

, , +17

Cytomegalovirus encodes a potent α chemokine

Mark E.T. Penfold, Daniel J. Dairaghi, Gregory Duke et al. · Proceedings of the National Academy of Sciences · 1999 · 335 citations · Full text

, , +17

Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10

Juliet V. Spencer, Kristen M. Lockridge, Peter A. Barry et al. · Journal of Virology · 2002 · 318 citations · Full text

, , +17

1–5 of 29